Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$11.38 - $19.03 $56,444 - $94,388
-4,960 Reduced 20.42%
19,326 $354,000
Q4 2023

Feb 13, 2024

SELL
$6.29 - $15.72 $6,717 - $16,788
-1,068 Reduced 4.21%
24,286 $297,000
Q3 2023

Nov 07, 2023

BUY
$14.99 - $32.65 $116,637 - $254,049
7,781 Added 44.28%
25,354 $380,000
Q2 2023

Aug 02, 2023

BUY
$29.76 - $46.14 $522,972 - $810,818
17,573 New
17,573 $570,000
Q2 2021

Aug 03, 2021

SELL
$44.66 - $63.06 $214,501 - $302,877
-4,803 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$46.31 - $62.7 $4,816 - $6,520
104 Added 2.21%
4,803 $243,000
Q4 2020

Feb 11, 2021

BUY
$55.51 - $69.94 $11,934 - $15,037
215 Added 4.79%
4,699 $296,000
Q3 2020

Nov 13, 2020

SELL
$42.19 - $69.61 $291,870 - $481,561
-6,918 Reduced 60.67%
4,484 $301,000
Q2 2020

Aug 11, 2020

BUY
$27.55 - $43.28 $314,125 - $493,478
11,402 New
11,402 $478,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.